When only patients with HCC beyond the Milan criteria were studied, a significant difference in RFS was found between the negative and positive IRF-1 expression groups (Figure 5B, P = 6.4 × 10−5). This evidence concerns the gene IRF1 and hepatocellular carcinoma.